NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Intensity Therapeutics, Inc. Common stock Share Price Chart

O H L

Intensity Therapeutics, Inc. Common stock Performance Overview

Days Range
$3.77Low
$3.80High

Markets Today

Previous Close$3.88
Open$3.80
Volume9,507
Day's Range$3.77 - $3.80
52W Range$3.51 - $43.50
Market Cap$12.44 M

Historical Performance

1M Returns-9.50
3M Returns-2.81
6M Returns-41.20
1Y Returns-36.50
5Y ReturnsNA
10Y ReturnsNA

Intensity Therapeutics, Inc. Common stock Fundamentals

Market Cap$12.44 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-1.57
EPS TTM$-4.93
Quarterly Earnings Growth YOYN/A
PB Ratio1.22
EBITDA$-11.97 M
Profit MarginN/A
Market Cap$12.44 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-1.57
EPS TTM$-4.93
Quarterly Earnings Growth YOYN/A
PB Ratio1.22
EBITDA$-11.97 M
Profit MarginN/A

Intensity Therapeutics, Inc. Common stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$3.39 M-$2.71 M-$2.73 M-$3.14 M-$2.53 M-$3.08 M
EBITDA -$3.39 M-$2.71 M-$2.73 M-$3.14 M-$2.53 M-$3.08 M
Interest Expense $0$0$0$0$0$0
Depreciation $0$0$0$0$0$0
Income Before Tax -$3.35 M-$2.54 M-$2.67 M-$3.05 M-$2.43 M-$3.01 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$3.35 M-$2.54 M-$2.67 M-$3.05 M-$2.43 M-$3.01 M
Net Profit Margin ------

Intensity Therapeutics, Inc. Common stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $2.00 K$3.00 K$5.00 K$0$0$0
Reserve & Surplus -$70.13 M-$72.67 M-$75.34 M-$78.39 M-$80.82 M-$83.83 M
Non-Current Liabilities $102.00 K$95.00 K$87.00 K$79.00 K$70.00 K$62.00 K
Current Liabilities $2.63 M$2.16 M$2.28 M$2.15 M$2.24 M$2.25 M
Total Liabilities $2.73 M$2.26 M$2.36 M$2.23 M$2.31 M$2.31 M
Fixed Assets $0$0$0$0$0$0
Current Assets $1.65 M$3.04 M$8.19 M$12.71 M$10.91 M$11.23 M
Total Assets $3.06 M$4.44 M$9.59 M$14.10 M$12.29 M$11.52 M

Intensity Therapeutics, Inc. Common stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$3.35 M-$2.54 M-$2.67 M-$3.05 M-$2.43 M-$3.01 M
Operating Cash Flow -$1.99 M-$2.46 M-$2.39 M-$2.40 M-$1.83 M-$2.34 M
Investing Cash Flow $0$0$0$0$0$0
Financing Cash Flow $328.00 K$3.74 M$7.24 M$7.25 M$150.00 K$1.62 M
Change in Cash -$1.66 M$1.29 M$4.85 M$4.85 M-$1.68 M-$716.00 K

Intensity Therapeutics, Inc. Common stock Return Calculator

The Intensity Therapeutics, Inc. Common stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About Intensity Therapeutics, Inc. Common stock

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

FAQs

Intensity Therapeutics, Inc. Common stock (INTS) share price as of September 18, 2026 is $3.75. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Intensity Therapeutics, Inc. Common stock (INTS) Share by opening an international trading account with Angel One.
Purchasing Intensity Therapeutics, Inc. Common stock (INTS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Intensity Therapeutics, Inc. Common stock (INTS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Intensity Therapeutics, Inc. Common stock (INTS) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Intensity Therapeutics, Inc. Common stock on September 18, 2026, is $12.44 M.
Intensity Therapeutics, Inc. Common stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Intensity Therapeutics, Inc. Common stock (INTS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91